Free Trial

United Services Automobile Association Acquires New Shares in HealthEquity, Inc. $HQY

HealthEquity logo with Medical background

Key Points

  • United Services Automobile Association acquired a new stake in HealthEquity, Inc. by purchasing 5,637 shares valued at approximately $490,000 in the first quarter of the year.
  • Insider activity noted that EVP Michael Henry Fiore sold 1,794 shares of HealthEquity for over $182,000, reducing their holdings and reflecting a 3.26% decrease in ownership.
  • Several analysts have increased their price targets for HealthEquity, with Bank of America raising their target from $110.00 to $125.00, reflecting a strong positive sentiment towards the company’s stock.
  • MarketBeat previews top five stocks to own in October.

United Services Automobile Association acquired a new stake in HealthEquity, Inc. (NASDAQ:HQY - Free Report) in the first quarter, according to the company in its most recent 13F filing with the SEC. The institutional investor acquired 5,637 shares of the company's stock, valued at approximately $490,000.

A number of other large investors have also made changes to their positions in HQY. Versant Capital Management Inc bought a new stake in shares of HealthEquity in the 1st quarter valued at $28,000. WPG Advisers LLC bought a new stake in shares of HealthEquity in the 1st quarter valued at $28,000. Northwestern Mutual Wealth Management Co. increased its position in shares of HealthEquity by 176.4% in the 1st quarter. Northwestern Mutual Wealth Management Co. now owns 655 shares of the company's stock valued at $58,000 after buying an additional 418 shares in the last quarter. Larson Financial Group LLC increased its position in shares of HealthEquity by 1,366.0% in the 1st quarter. Larson Financial Group LLC now owns 689 shares of the company's stock valued at $61,000 after buying an additional 642 shares in the last quarter. Finally, BI Asset Management Fondsmaeglerselskab A S bought a new stake in shares of HealthEquity in the 1st quarter valued at $65,000. Institutional investors own 99.55% of the company's stock.

Insider Activity at HealthEquity

In other news, EVP Michael Henry Fiore sold 1,794 shares of the stock in a transaction dated Monday, July 7th. The shares were sold at an average price of $101.73, for a total transaction of $182,503.62. Following the completion of the transaction, the executive vice president directly owned 53,225 shares in the company, valued at $5,414,579.25. This represents a 3.26% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. 1.50% of the stock is currently owned by corporate insiders.

HealthEquity Trading Down 1.6%

HealthEquity stock opened at $91.51 on Thursday. The firm has a 50-day moving average of $93.74 and a 200-day moving average of $94.72. HealthEquity, Inc. has a one year low of $74.07 and a one year high of $116.65. The company has a debt-to-equity ratio of 0.47, a current ratio of 4.23 and a quick ratio of 4.23. The company has a market cap of $7.88 billion, a price-to-earnings ratio of 55.46, a P/E/G ratio of 1.33 and a beta of 0.50.

Analysts Set New Price Targets

A number of research firms have issued reports on HQY. Bank of America increased their target price on HealthEquity from $110.00 to $125.00 and gave the stock a "buy" rating in a report on Wednesday, June 4th. Barrington Research reiterated an "outperform" rating and set a $125.00 target price on shares of HealthEquity in a report on Friday, August 29th. Royal Bank Of Canada increased their target price on HealthEquity from $109.00 to $110.00 and gave the stock an "outperform" rating in a report on Wednesday, September 3rd. Raymond James Financial reiterated a "strong-buy" rating and set a $120.00 target price (up previously from $115.00) on shares of HealthEquity in a report on Tuesday, July 8th. Finally, JMP Securities increased their target price on HealthEquity from $110.00 to $117.00 and gave the stock a "market outperform" rating in a report on Wednesday, June 4th. One research analyst has rated the stock with a Strong Buy rating, eleven have assigned a Buy rating and one has given a Hold rating to the company's stock. Based on data from MarketBeat.com, HealthEquity presently has an average rating of "Buy" and an average target price of $119.77.

Check Out Our Latest Analysis on HQY

About HealthEquity

(Free Report)

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.

Further Reading

Want to see what other hedge funds are holding HQY? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HealthEquity, Inc. (NASDAQ:HQY - Free Report).

Institutional Ownership by Quarter for HealthEquity (NASDAQ:HQY)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in HealthEquity Right Now?

Before you consider HealthEquity, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and HealthEquity wasn't on the list.

While HealthEquity currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

Reduce the Risk Cover

Market downturns give many investors pause, and for good reason. Wondering how to offset this risk? Enter your email address to learn more about using beta to protect your portfolio.

Get This Free Report
Like this article? Share it with a colleague.